The microbial metabolite, Urolithin A, derived from a compound found in berries and pomegranates, can reduce and protect against inflammatory bowel disease (IBD). Urolithin A (UroA) and its synthetic counterpart, UAS03, mitigate IBD by increasing proteins that tighten epithelial cell junctions in the gut and reducing gut inflammation in animal models. Tight junctions in the gut barrier prevent inappropriate microorganisms and toxins from leaking out, causing inflammation characteristic of IBD.
March 17, 2013
September 26, 2018
In Depth Search (Advanced)
Subscribe to Blog via Email
Top Posts & Pages
- 100% Remission rate for Multiple Sclerosis in rats with Calcitriol and D3.. With possible human protocols
- Study: Whooping cough resurgence due to vaccinated people not knowing they're infectious?
- Vaccines that Contain Latex ;CDC PINKBOOK Feb 2015 ;Packaging Exposure
- Influenza A vaccination associated with 6.3 times more aerosol shedding than non vaccinated
- Bedtime protein for bigger gains? Here’s the scoop
- Inactive ingredients in pills and capsules may cause allergic, adverse reactions
- Revealed: Army scientists secretly sprayed St Louis with ‘radioactive’ particles for YEARS to test chemical warfare technology
- 'Inflamm-aging' causes loss of bone healing ability in the elderly
- Bacteria found in ancient Irish soil halts growth of superbugs -- new hope for tackling antibiotic resistance
- Scientists identify compounds in coffee which may inhibit prostate cancer